Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Jia Liu is a Nephrologist in Columbia, Maryland. Dr. Liu is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and Chronic Kidney Disease.

Dr. Parikh received his medical degree from Seth G.S. Medical College and KEM Hospital in Mumbai, India and subsequently completed his Nephrology fellowship and a PhD in Clinical Investigation at the University of Colorado Health Sciences Center. Dr. Parikh’s research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Progress in kidney diseases has been hamstrung by significant heterogeneity within the current disease definitions, which are largely based on serum creatinine. Dr. Parikh’s research has addressed this critical challenge by developing biomarkers of renal tubular injury, repair, and inflammation to dissect this heterogeneity. He has assembled multicenter longitudinal prospective cohorts for translational research studies across several clinical settings of acute kidney injury and chronic kidney disease for the efficient translation of novel biomarkers. His research is dedicated to the process of applying discoveries generated in the laboratory and in preclinical experiments, the development of clinical studies, and the design of clinical trials. Dr. Parikh’s studies have refined the clinical definition in perioperative acute kidney injury and hepatorenal syndrome, developed strategies to reduce kidney discard in deceased donor transplantation, and advanced regulatory approvals of kidney injury biomarkers. He has also developed biomarkers to identify rapid progressors of early diabetic kidney disease before derangements in serum creatinine. Dr. Parikh’s research goal is to translate our understanding of pathophysiological mechanisms into clinical practice and improve the outcomes in patients with kidney disease. Dr. Parikh has also been the recipient of numerous honors, including the 2017 Young Investigator Award from the American Society of Nephrology. Dr. Parikh is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Interstitial Nephritis, Acute Tubular Necrosis, Prerenal Azotemia, Kidney Transplant, and Nephrectomy.

Matthew Weir is a Nephrologist in Baltimore, Maryland. Dr. Weir is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are High Potassium Level, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Kidney Transplant, and Nephrectomy. Dr. Weir is currently accepting new patients.

Mary Pieprzak is a Nephrologist in Columbia, Maryland. Dr. Pieprzak is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and Chronic Kidney Disease.

Ping-hsin Chen is a Nephrologist in Columbia, Maryland. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Renovascular Hypertension, Acute Kidney Failure, Acute Tubular Necrosis, and Nephrosclerosis.

Tin Maung is a Nephrologist in Columbia, Maryland. Dr. Maung is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Acute Kidney Failure.

Kathryn Ratanavanich is a Nephrologist in Silver Spring, Maryland. Dr. Ratanavanich is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Diabetic Nephropathy, and Acute Tubular Necrosis.

Oney Zuniga is a Nephrologist in Olney, Maryland. Dr. Zuniga is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Diabetic Nephropathy, Magnesium Deficiency, Gitelman Syndrome, Gastrostomy, and Endoscopy. Dr. Zuniga is currently accepting new patients.

Muneeb Malik is a Nephrologist in Hagerstown, Maryland. Dr. Malik is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Diabetic Nephropathy, and Acute Kidney Failure. Dr. Malik is currently accepting new patients.

Adebowale Prest is a primary care provider, practicing in Family Medicine in Cambridge, Maryland. Dr. Prest is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are High Cholesterol, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Familial Hypertension. Dr. Prest is currently accepting new patients.

Mahrukh Hussain is a primary care provider, practicing in Family Medicine in Gaithersburg, Maryland. Dr. Hussain is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Diabetic Nephropathy, Ballinger-Wallace Syndrome, Type 2 Diabetes (T2D), and Diabetic Hyperglycemic Hyperosmolar Syndrome. Dr. Hussain is currently accepting new patients.

Jeffrey Posner is a Nephrologist in Owings Mills, Maryland. Dr. Posner is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Chronic Kidney Disease. Dr. Posner is currently accepting new patients.

Olufunmilayo Onobrakpeya is an Endocrinologist in Bel Air, Maryland. Dr. Onobrakpeya is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Nephropathy, Thyroid Nodule, and Paget's Disease of Bone.

Akshay Amin is a Nephrologist in Lutherville, Maryland. Dr. Amin is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Diabetic Nephropathy. Dr. Amin is currently accepting new patients.

Ajay Kumar is a Nephrologist in Columbia, Maryland. Dr. Kumar is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Acute Kidney Failure, Nephrosclerosis, Renovascular Hypertension, and Acute Tubular Necrosis.

Anita Pasumarthy is a Nephrologist in Baltimore, Maryland. Dr. Pasumarthy is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Chronic Kidney Disease.

Dr. Steven A. Burka is a nephrologist affiliated with Sibley Memorial Hospital and Suburban Hospital. He has a private practice in Chevy Chase, Md. Dr. Burka earned his medical degree from George Washington University School of Medicine. He completed a residency in internal medicine at Beth Israel Medical Center, followed by residencies in nephrology at Bellevue Hospital Center and New York University Medical Center. Dr. Burka was named a Top Doctor in the Washington, D.C. and Washington-Baltimore areas by Castle Connolly in 2012. Videos 2017 Best Consulting Physician at Sibley Memorial Hospital - Steven Burka, M.D. Dr. Burka is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Chronic Kidney Disease, High Potassium Level, End-Stage Renal Disease (ESRD), and Low Sodium Level.

Rao Khan is a Nephrologist in Columbia, Maryland. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, Chronic Kidney Disease, and Endoscopy.

Mohammad Khan is a Nephrologist in Chevy Chase, Maryland. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Nephrosclerosis.